Inflammation Marker Linked to Higher Cancer Mortality

In men, elevated high-sensitivity C-reactive protein levels linked to higher all-cause, cancer death

WEDNESDAY, Nov. 7 (HealthDay News) -- Elevated serum levels of high-sensitivity C-reactive protein (hs-CRP), a marker of chronic inflammation, correlate with increased mortality from all causes and cancer in men but not in women, according to research published in the November issue of Cancer Epidemiology, Biomarkers & Prevention.

To examine the correlation between serum hs-CRP levels and all-cause, cancer, and site-specific cancer mortality, Young-Jin Ko, of the Seoul National University Hospital in South Korea, and colleagues conducted a retrospective study involving 33,567 apparently cancer-free Korean adults who underwent routine check-ups and measurement of serum hs-CRP levels between May 1995 and December 2006.

During an average follow-up of 9.4 years, the researchers found that men with an hs-CRP level of ≥3 mg/L versus ≤1 mg/L had an adjusted hazard ratio of 1.38 for all-cause mortality and 1.61 for cancer-related mortality. For women, the corresponding adjusted hazard ratios were 1.29 (95 percent confidence interval [CI], 0.94 to 1.77) and 1.24 (95 percent CI, 0.75 to 2.06), respectively. For both sexes combined, elevated hs-CRP correlated with an increased risk of site-specific mortality for lung cancer (adjusted hazard ratio, 2.53).

"In the future, assessment of the level of serum hs-CRP, a marker of chronic low-grade inflammation, might help identify subjects at increased risk of cancer death," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events